TL;DR
Get comfort and care essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A study in Nature Communications linked imidazole propionate, a molecule made by some gut bacteria, with Alzheimer’s-related biological markers and faster cognitive decline. Mouse experiments found effects on amyloid and tau, while the human findings are associations and do not prove ImP causes Alzheimer’s or that lowering it prevents the disease.
Researchers report that imidazole propionate (ImP), a molecule produced by some gut bacteria, may be linked to biological changes associated with Alzheimer’s disease. In a study published in Nature Communications, ImP affected amyloid and tau accumulation in mice, while higher blood levels in nearly 1,200 people were associated with dementia-related markers and faster cognitive decline; the human findings do not establish that ImP causes Alzheimer’s.
The team, led by researchers at the University of Wisconsin–Madison, studied ImP because it is produced by certain intestinal bacteria and can enter the bloodstream. The molecule’s production varies among people. Researchers say the bacteria that make it occur in many people but are generally not abundant, a finding that suggests a microbe’s effects need not depend on its numbers.
In mouse experiments, ImP that reached the brain increased the accumulation of abnormal beta-amyloid and tau proteins, which are associated with Alzheimer’s disease. The researchers say those results point to a possible biological route connecting a gut-produced compound with brain changes. Mouse findings, however, cannot by themselves establish what the molecule does in people.
For the human analysis, the researchers examined blood samples from almost 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies run through the Wisconsin Alzheimer’s Disease Research Center. Higher ImP concentrations were associated with biological markers of abnormal protein accumulation and impaired neuron function. Participants with the highest levels also showed faster decline on cognitive tests taken over time, according to the researchers. The report does not establish that ImP caused those changes.
A Possible Target Beyond Diet
The results identify ImP as a candidate for further study in research on dementia risk. If later work establishes that the molecule contributes to disease processes in people, reducing its levels could offer a way to investigate prevention or slowing cognitive decline. The study does not show that an ImP-lowering treatment exists or would work.
The finding also points to a potential challenge: the bacteria produce ImP while using histidine, an amino acid people need and obtain from many foods. The researchers caution against reducing the result to advice to avoid particular foods. They suggest a future treatment might target ImP itself or its production rather than remove histidine from the diet. That remains a research possibility, not a current recommendation.
As an affiliate, we earn on qualifying purchases.
From Gut Differences to ImP
The Wisconsin research team had previously reported differences in gut microorganisms between people with Alzheimer’s and healthy individuals. The group has since investigated whether those differences relate to changes in the brain. This study focuses on one bacterial product rather than treating the gut microbiome as a single, uniform factor.
Earlier research had linked ImP with type 2 diabetes and coronary artery disease, according to the report. The new work extends the question to brain health. Researchers also identified a genetic variation associated with substantially higher ImP levels in the bloodstream; about 43% of study participants carried it. The team suspects it may affect how efficiently the kidneys clear ImP, but that explanation remains a hypothesis.
“Since then, we’ve been trying to figure out how this difference in the gut perhaps leads to changes in the brain.”
— Barbara Bendlin, University of Wisconsin–Madison professor of medicine
brain health supplements for memory
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Cause and Treatment Remain Unproven
The human results show associations, not proof that ImP causes Alzheimer’s disease or speeds decline. Other factors could contribute to the relationship, and the supplied report does not detail whether the analysis accounted for all possible influences. The mouse experiments support a possible mechanism but cannot settle the question for humans.
It is also unclear how ImP levels vary across the wider population, what determines an individual’s level, and whether changing those levels would alter dementia risk. The proposed role of the genetic variation in kidney clearance has not been confirmed in the report. No ImP-targeting drug or prevention strategy was tested.
As an affiliate, we earn on qualifying purchases.
Testing ImP as a Treatment Target
The next steps are to test whether the associations hold in additional groups and to clarify how ImP may affect the brain and how the genetic variation relates to blood levels. Researchers would also need to determine whether an intervention can safely reduce ImP and whether doing so changes Alzheimer’s-related outcomes. Until such evidence is available, the study supports further investigation rather than a change in diet or medical care.
The report says scientists from the University of California, Los Angeles and the University of Gothenburg also contributed. The research received support from the Wisconsin Partnership Program, the National Institutes of Health and the U.S. Department of Agriculture.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is imidazole propionate?
Imidazole propionate, or ImP, is a compound produced by some gut bacteria as they use histidine, an amino acid. It can enter the bloodstream, according to the researchers.
Does this study prove ImP causes Alzheimer’s disease?
No. The human findings link higher blood ImP with Alzheimer’s-related markers and faster cognitive decline, but they do not prove cause and effect. The reported effects on amyloid and tau came from mouse experiments.
Should people avoid certain foods to lower ImP?
The study does not provide a dietary recommendation. Histidine is essential and found in many foods, and the researchers said reducing ImP through diet may not be straightforward. No specific food-avoidance plan was tested.
Is there a treatment that lowers ImP?
The report describes an ImP-lowering treatment as a possible future research direction. It does not identify an available drug or show that reducing ImP prevents Alzheimer’s or slows cognitive decline.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
